This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Amicogen Co., Ltd., Amicogen, Inc.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Ho Seung Chung: Innovator in Lycopene Production
Introduction
Ho Seung Chung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of lycopene through innovative methods involving recombinant bacterial strains. With a total of 2 patents, Chung's work is paving the way for advancements in this area.
Latest Patents
Chung's latest patents focus on methods for producing lycopene with high productivity. One patent describes a method that includes preparing a recombinant vector containing genes necessary for lycopene biosynthesis. The genes involved are crtE, crtB, and crtI, with specific nucleotide sequences identified for each. The recombinant vector is transformed into a bacterial strain, which is then cultured to recover lycopene from the culture medium. Another patent outlines a similar method, emphasizing the selection of at least one of the three genes for the production process.
Career Highlights
Throughout his career, Ho Seung Chung has worked with prominent companies in the biotechnology sector, including Amicogen Co., Ltd. and Amicogen, Inc. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.
Collaborations
Chung has collaborated with notable colleagues such as Jong Keun Kim and Nahm Ryune Cho. These partnerships have likely enhanced his research capabilities and contributed to the successful development of his patented methods.
Conclusion
Ho Seung Chung is a distinguished inventor whose work in lycopene production showcases the potential of biotechnology. His innovative methods and collaborations highlight the importance of research in advancing this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile